7-Chlorokynurenic acid: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== 7-Chlorokynurenic Acid == | |||
[[File:7-Chlorokynurenic_acid.svg|thumb|right|Chemical structure of 7-Chlorokynurenic acid]] | |||
'''7-Chlorokynurenic acid''' is a synthetic compound that acts as a potent and selective antagonist of the [[glycine]] site of the [[N-methyl-D-aspartate receptor|NMDA receptor]]. It is a derivative of [[kynurenic acid]], which is an endogenous neuroactive metabolite of the amino acid [[tryptophan]]. | |||
7-Chlorokynurenic acid is a derivative of [[kynurenic acid]], which is | |||
== | == Chemical Properties == | ||
7-Chlorokynurenic acid is characterized by the presence of a chlorine atom at the 7-position of the kynurenic acid molecule. This modification enhances its ability to bind to the glycine site of the NMDA receptor, thereby inhibiting the receptor's activity. The chemical structure of 7-Chlorokynurenic acid is depicted in the adjacent image. | |||
7-Chlorokynurenic acid is | |||
== | == Mechanism of Action == | ||
==Related | The NMDA receptor is a type of [[glutamate receptor]] that plays a crucial role in [[synaptic plasticity]] and [[memory]] function. It requires the binding of both glutamate and glycine to become fully activated. 7-Chlorokynurenic acid competes with glycine for binding to its site on the NMDA receptor, thereby preventing receptor activation. This makes it a useful tool in research for studying the role of NMDA receptors in various physiological and pathological processes. | ||
== Applications in Research == | |||
7-Chlorokynurenic acid is widely used in [[neuroscience]] research to investigate the role of NMDA receptors in [[neurodegenerative diseases]], [[schizophrenia]], and [[pain]] management. By blocking the glycine site, researchers can study the effects of reduced NMDA receptor activity in various experimental models. | |||
== Potential Therapeutic Uses == | |||
There is ongoing research into the potential therapeutic applications of 7-Chlorokynurenic acid and similar compounds. Due to its ability to modulate NMDA receptor activity, it is being explored as a potential treatment for conditions such as [[Alzheimer's disease]], [[Parkinson's disease]], and [[chronic pain]]. However, more research is needed to fully understand its efficacy and safety in clinical settings. | |||
== Related Pages == | |||
* [[Kynurenic acid]] | |||
* [[NMDA receptor]] | * [[NMDA receptor]] | ||
* [[ | * [[Glycine]] | ||
* [[Glutamate receptor]] | * [[Glutamate receptor]] | ||
{{Neuropharmacology}} | |||
[[Category: | [[Category:NMDA receptor antagonists]] | ||
[[Category: | [[Category:Chlorine compounds]] | ||
[[Category: | [[Category:Neuropharmacology]] | ||
Latest revision as of 16:31, 16 February 2025
7-Chlorokynurenic Acid[edit]
7-Chlorokynurenic acid is a synthetic compound that acts as a potent and selective antagonist of the glycine site of the NMDA receptor. It is a derivative of kynurenic acid, which is an endogenous neuroactive metabolite of the amino acid tryptophan.
Chemical Properties[edit]
7-Chlorokynurenic acid is characterized by the presence of a chlorine atom at the 7-position of the kynurenic acid molecule. This modification enhances its ability to bind to the glycine site of the NMDA receptor, thereby inhibiting the receptor's activity. The chemical structure of 7-Chlorokynurenic acid is depicted in the adjacent image.
Mechanism of Action[edit]
The NMDA receptor is a type of glutamate receptor that plays a crucial role in synaptic plasticity and memory function. It requires the binding of both glutamate and glycine to become fully activated. 7-Chlorokynurenic acid competes with glycine for binding to its site on the NMDA receptor, thereby preventing receptor activation. This makes it a useful tool in research for studying the role of NMDA receptors in various physiological and pathological processes.
Applications in Research[edit]
7-Chlorokynurenic acid is widely used in neuroscience research to investigate the role of NMDA receptors in neurodegenerative diseases, schizophrenia, and pain management. By blocking the glycine site, researchers can study the effects of reduced NMDA receptor activity in various experimental models.
Potential Therapeutic Uses[edit]
There is ongoing research into the potential therapeutic applications of 7-Chlorokynurenic acid and similar compounds. Due to its ability to modulate NMDA receptor activity, it is being explored as a potential treatment for conditions such as Alzheimer's disease, Parkinson's disease, and chronic pain. However, more research is needed to fully understand its efficacy and safety in clinical settings.
Related Pages[edit]
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
